MedPath

App for Reducing Cravings to Smoke

Phase 2
Recruiting
Conditions
Smoking
Registration Number
NCT06088498
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Brief Summary

The overall goal of the study is to assess the efficacy of using cue exposure delivered via a smartphone application as an adjunct to Tobacco Quitline treatment to improve smoking abstinence.

Detailed Description

The aims of the study are: (1) to update a recently developed study-related smartphone application to reduce cravings to smoke to be an engaging, user-friendly treatment tool, and verify user satisfaction; and (2) to test in a randomized controlled trial the efficacy of the app as an adjunct to quitline smoking cessation treatment in improving smoking abstinence compared to the quitline only.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
3600
Inclusion Criteria
  • >18 years of age
  • Daily smokers that have quit smoking within the past 3 months (Aim 1) or currently smoking ≥ 3 cigarettes per day for the past year (Aim 2)
  • Functioning telephone number
  • Owns a smart phone capable of supporting AR and willing to download the app
  • Can speak, read and write in English
Exclusion Criteria
  • Has another household member already enrolled in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Tobacco Abstinence (Aim 2)At 6 Months

Self-report of no combustible tobacco use in the past 7 days

System Usability Scale (Aim 1)At 1 Week

Participants' perception of usability and learnability of the app will be measured using 10 items on a 5-point Likert scale. Scores range from 0 to 100, with higher scores indicating better usability.

Secondary Outcome Measures
NameTimeMethod
User Satisfaction (Aim 1)At 1 Week

One Likert scale item will capture participants' satisfaction with the app. The Likert scale is from 1 to 4, with higher score indicating greater satisfaction.

Trial Locations

Locations (1)

Moffitt Cancer Center

🇺🇸

Tampa, Florida, United States

Moffitt Cancer Center
🇺🇸Tampa, Florida, United States
Karen Brandon
Contact
813-745-7691
karen.brandon@moffitt.org
Marilyn Horta, PhD
Contact
Christine Vinci, PhD
Principal Investigator
Thomas Brandon, PhD
Sub Investigator
Margaret Byrne, PhD
Sub Investigator
Kea Turner, PhD
Sub Investigator
Damon Vadrine, DRPH
Sub Investigator
Lee Ritterbrand, PhD
Sub Investigator
Kara Wiseman, PhD, MPH
Sub Investigator
Katrina Vickerman, PhD
Sub Investigator
Steve Sutton, PhD
Sub Investigator
© Copyright 2025. All Rights Reserved by MedPath